3,419 Shares in HCA Healthcare, Inc. (NYSE:HCA) Bought by Numerai GP LLC

Numerai GP LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,419 shares of the company's stock, valued at approximately $1,026,000.

Other large investors have also recently bought and sold shares of the company. Norges Bank acquired a new position in HCA Healthcare in the fourth quarter valued at approximately $840,286,000. Royal London Asset Management Ltd. boosted its stake in HCA Healthcare by 62.0% during the fourth quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company's stock worth $450,461,000 after acquiring an additional 574,239 shares in the last quarter. Barclays PLC boosted its position in shares of HCA Healthcare by 85.7% during the 4th quarter. Barclays PLC now owns 1,061,891 shares of the company's stock worth $318,727,000 after purchasing an additional 489,916 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in HCA Healthcare by 120.1% in the fourth quarter. Principal Financial Group Inc. now owns 873,775 shares of the company's stock worth $262,264,000 after acquiring an additional 476,756 shares in the last quarter. Finally, Consulta Ltd lifted its holdings in shares of HCA Healthcare by 100.0% in the 4th quarter. Consulta Ltd now owns 550,000 shares of the company's stock worth $165,082,000 after purchasing an additional 275,000 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer now directly owns 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Performance

Shares of NYSE:HCA traded down $0.19 during mid-day trading on Tuesday, reaching $386.70. The company had a trading volume of 342,160 shares, compared to its average volume of 1,664,366. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The company's 50-day moving average price is $342.18 and its 200-day moving average price is $328.51. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The firm has a market cap of $93.03 billion, a price-to-earnings ratio of 17.60, a PEG ratio of 1.10 and a beta of 1.46.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The firm's revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the firm posted $5.36 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.74%. HCA Healthcare's dividend payout ratio is currently 12.81%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on HCA shares. Bank of America decreased their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research report on Monday, January 27th. Royal Bank of Canada lowered their price objective on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. StockNews.com upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Baird R W downgraded shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Finally, Barclays dropped their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $381.13.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.